| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -220 @ USD 119.18 | USD -26,220 | The ETF sold 220 shares of DVA on 2025-12-02. The shares were previously bought for an average price of USD 143.535. The DaVita HealthCare Partners Inc shares were sold for -17.0% lower than average price of previous purchases. This resulted in an overall loss of USD 5,358 The average price that the ETF previously sold DVA share for is USD 142.456 which is higher than the selling price of USD 119.18 on 2025-12-02. |
| HSIC - Henry Schein Inc | SELL | -638 @ USD 71.67 | USD -45,725 | The ETF sold 638 shares of HSIC on 2025-12-02. The shares were previously bought for an average price of USD 71.1823. The Henry Schein Inc shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 311 The average price that the ETF previously sold HSIC share for is USD 69.8318 so the ETF has sold 638 shares on 2025-12-02 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -330 @ USD 145.97 | USD -48,170 | The ETF sold 330 shares of MOH on 2025-12-02. The shares were previously bought for an average price of USD 253.075. The MOH shares were sold for -42.3% lower than average price of previous purchases. This resulted in an overall loss of USD 35,345 The average price that the ETF previously sold MOH share for is USD 290.008 which is higher than the selling price of USD 145.97 on 2025-12-02. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -330 @ USD 145.97 | USD -48,170 | The ETF sold 330 shares of MOH on 2025-12-02. The shares were previously bought for an average price of USD 253.075. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -42.3% lower than average price of previous purchases. This resulted in an overall loss of USD 35,345 The average price that the ETF previously sold MOH share for is USD 290.008 which is higher than the selling price of USD 145.97 on 2025-12-02. |
| MRNA - Moderna Inc | SELL | -2,112 @ USD 24.06 | USD -50,815 | The ETF sold 2112 shares of MRNA on 2025-12-02. The shares were previously bought for an average price of USD 31.1562. The Moderna Inc shares were sold for -22.8% lower than average price of previous purchases. This resulted in an overall loss of USD 14,987 The average price that the ETF previously sold MRNA share for is USD 36.9792 which is higher than the selling price of USD 24.06 on 2025-12-02. |
| CRL - Creightons Plc | SELL | -297 @ USD 174.76 | USD -51,904 | The ETF sold 297 shares of CRL on 2025-12-02. The shares were previously bought for an average price of USD 167.983. The Creightons Plc shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of USD 2,013 The average price that the ETF previously sold CRL share for is USD 173.661 so the ETF has sold 297 shares on 2025-12-02 at a higher price than the previous selling average. |
| BAX - Baxter International Inc | SELL | -3,157 @ USD 18.84 | USD -59,478 | The ETF sold 3157 shares of BAX on 2025-12-02. The shares were previously bought for an average price of USD 28.4174. The Baxter International Inc shares were sold for -33.7% lower than average price of previous purchases. This resulted in an overall loss of USD 30,236 The average price that the ETF previously sold BAX share for is USD 31.1514 which is higher than the selling price of USD 18.84 on 2025-12-02. |
| TECH - Bio-Techne Corp | SELL | -957 @ USD 62.95 | USD -60,243 | The ETF sold 957 shares of TECH on 2025-12-02. The shares were previously bought for an average price of USD 62.3914. The Bio-Techne Corp shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 535 The average price that the ETF previously sold TECH share for is USD 65.0115 which is higher than the selling price of USD 62.95 on 2025-12-02. |
| ALGN - Align Technology Inc | SELL | -407 @ USD 150.93 | USD -61,429 | The ETF sold 407 shares of ALGN on 2025-12-02. The shares were previously bought for an average price of USD 171.385. The Align Technology Inc shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of USD 8,325 The average price that the ETF previously sold ALGN share for is USD 199.421 which is higher than the selling price of USD 150.93 on 2025-12-02. |
| RVTY - Revvity Inc. | SELL | -726 @ USD 102.73 | USD -74,582 | The ETF sold 726 shares of RVTY on 2025-12-02. The shares were previously bought for an average price of USD 105.147. The Revvity Inc. shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,755 The average price that the ETF previously sold RVTY share for is USD 106.627 which is higher than the selling price of USD 102.73 on 2025-12-02. |
| VTRS - Viatris Inc | SELL | -7,095 @ USD 10.71 | USD -75,987 | The ETF sold 7095 shares of VTRS on 2025-12-02. The shares were previously bought for an average price of USD 10.2561. The Viatris Inc shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 3,220 The average price that the ETF previously sold VTRS share for is USD 10.9681 which is higher than the selling price of USD 10.71 on 2025-12-02. |
| SOLV - Solventum Corp. | SELL | -902 @ USD 85.59 | USD -77,202 | The ETF sold 902 shares of SOLV on 2025-12-02. The shares were previously bought for an average price of USD 74.1326. The Solventum Corp. shares were sold for 15.5% higher than average price of previous purchases. This sale made a profit of USD 10,335 The average price that the ETF previously sold SOLV share for is USD 72.1747 so the ETF has sold 902 shares on 2025-12-02 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -341 @ USD 238.68 | USD -81,390 | The ETF sold 341 shares of UHS on 2025-12-02. The shares were previously bought for an average price of USD 197.686. The Universal Health Services Inc shares were sold for 20.7% higher than average price of previous purchases. This sale made a profit of USD 13,979 The average price that the ETF previously sold UHS share for is USD 194.352 so the ETF has sold 341 shares on 2025-12-02 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -1,232 @ USD 75.84 | USD -93,435 | The ETF sold 1232 shares of COO on 2025-12-02. The shares were previously bought for an average price of USD 81.8467. The The Cooper Companies, Inc. Common Stock shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 7,400 The average price that the ETF previously sold COO share for is USD 88.9074 which is higher than the selling price of USD 75.84 on 2025-12-02. |
| HOLX - Hologic Inc | SELL | -1,364 @ USD 74.82 | USD -102,054 | The ETF sold 1364 shares of HOLX on 2025-12-02. The shares were previously bought for an average price of USD 68.2129. The Hologic Inc shares were sold for 9.7% higher than average price of previous purchases. This sale made a profit of USD 9,012 The average price that the ETF previously sold HOLX share for is USD 70.6716 so the ETF has sold 1364 shares on 2025-12-02 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -1,012 @ USD 101.44 | USD -102,657 | The ETF sold 1012 shares of INCY on 2025-12-02. The shares were previously bought for an average price of USD 78.4776. The Incyte Corporation shares were sold for 29.3% higher than average price of previous purchases. This sale made a profit of USD 23,238 The average price that the ETF previously sold INCY share for is USD 74.6587 so the ETF has sold 1012 shares on 2025-12-02 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -2,871 @ USD 38.81 | USD -111,424 | The ETF sold 2871 shares of CNC on 2025-12-02. The shares were previously bought for an average price of USD 50.8192. The Concurrent Technologies Plc shares were sold for -23.6% lower than average price of previous purchases. This resulted in an overall loss of USD 34,478 The average price that the ETF previously sold CNC share for is USD 51.0019 which is higher than the selling price of USD 38.81 on 2025-12-02. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -1,210 @ USD 94.14 | USD -113,909 | The ETF sold 1210 shares of ZBH on 2025-12-02. The shares were previously bought for an average price of USD 102.119. The Zimmer Biomet Holdings Inc shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,655 The average price that the ETF previously sold ZBH share for is USD 103.811 which is higher than the selling price of USD 94.14 on 2025-12-02. |
| WST - West Pharmaceutical Services Inc | SELL | -429 @ USD 273.03 | USD -117,130 | The ETF sold 429 shares of WST on 2025-12-02. The shares were previously bought for an average price of USD 260.885. The West Pharmaceutical Services Inc shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 5,210 The average price that the ETF previously sold WST share for is USD 278.599 which is higher than the selling price of USD 273.03 on 2025-12-02. |
| DGX - Quest Diagnostics Incorporated | SELL | -671 @ USD 182.55 | USD -122,491 | The ETF sold 671 shares of DGX on 2025-12-02. The shares were previously bought for an average price of USD 173.599. The Quest Diagnostics Incorporated shares were sold for 5.2% higher than average price of previous purchases. This sale made a profit of USD 6,006 The average price that the ETF previously sold DGX share for is USD 167.201 so the ETF has sold 671 shares on 2025-12-02 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -429 @ USD 309 | USD -132,561 | The ETF sold 429 shares of PODD on 2025-12-02. The shares were previously bought for an average price of USD 292.021. The Insulet Corporation shares were sold for 5.8% higher than average price of previous purchases. This sale made a profit of USD 7,284 The average price that the ETF previously sold PODD share for is USD 278.96 so the ETF has sold 429 shares on 2025-12-02 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -506 @ USD 265.93 | USD -134,561 | The ETF sold 506 shares of LH on 2025-12-02. The shares were previously bought for an average price of USD 254.641. The Laboratory Corporation of America Holdings shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 5,712 The average price that the ETF previously sold LH share for is USD 244.856 so the ETF has sold 506 shares on 2025-12-02 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -363 @ USD 398.62 | USD -144,699 | The ETF sold 363 shares of WAT on 2025-12-02. The shares were previously bought for an average price of USD 360.014. The Waters Corporation shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 14,014 The average price that the ETF previously sold WAT share for is USD 362.621 so the ETF has sold 363 shares on 2025-12-02 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -363 @ USD 398.62 | USD -144,699 | The ETF sold 363 shares of WAT on 2025-12-02. The shares were previously bought for an average price of USD 360.014. The MULETFWATIMETFP shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 14,014 The average price that the ETF previously sold WAT share for is USD 362.621 so the ETF has sold 363 shares on 2025-12-02 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -594 @ USD 259.3 | USD -154,024 | The ETF sold 594 shares of STE on 2025-12-02. The shares were previously bought for an average price of USD 233.049. The STERIS plc shares were sold for 11.3% higher than average price of previous purchases. This sale made a profit of USD 15,593 The average price that the ETF previously sold STE share for is USD 225.833 so the ETF has sold 594 shares on 2025-12-02 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -2,398 @ USD 64.45 | USD -154,551 | The ETF sold 2398 shares of DXCM on 2025-12-02. The shares were previously bought for an average price of USD 73.4548. The DexCom Inc shares were sold for -12.3% lower than average price of previous purchases. This resulted in an overall loss of USD 21,594 The average price that the ETF previously sold DXCM share for is USD 76.1479 which is higher than the selling price of USD 64.45 on 2025-12-02. |
| BIIB - Biogen Inc | SELL | -891 @ USD 180.18 | USD -160,540 | The ETF sold 891 shares of BIIB on 2025-12-02. The shares were previously bought for an average price of USD 146.535. The Biogen Inc shares were sold for 23.0% higher than average price of previous purchases. This sale made a profit of USD 29,978 The average price that the ETF previously sold BIIB share for is USD 151.909 so the ETF has sold 891 shares on 2025-12-02 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -121 @ USD 1447.16 | USD -175,106 | The ETF sold 121 shares of MTD on 2025-12-02. The shares were previously bought for an average price of USD 1287.99. The Mettler-Toledo International Inc shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 19,260 The average price that the ETF previously sold MTD share for is USD 1245.66 so the ETF has sold 121 shares on 2025-12-02 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -121 @ USD 1447.16 | USD -175,106 | The ETF sold 121 shares of MTD on 2025-12-02. The shares were previously bought for an average price of USD 1287.99. The AMUNDI EUR GOV 710 shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 19,260 The average price that the ETF previously sold MTD share for is USD 1245.66 so the ETF has sold 121 shares on 2025-12-02 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -726 @ USD 241.96 | USD -175,663 | The ETF sold 726 shares of HUM on 2025-12-02. The shares were previously bought for an average price of USD 262.534. The Hummingbird Resources PLC shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 14,937 The average price that the ETF previously sold HUM share for is USD 269.946 which is higher than the selling price of USD 241.96 on 2025-12-02. |
| HUM - Humana Inc | SELL | -726 @ USD 241.96 | USD -175,663 | The ETF sold 726 shares of HUM on 2025-12-02. The shares were previously bought for an average price of USD 262.534. The Humana Inc shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 14,937 The average price that the ETF previously sold HUM share for is USD 269.946 which is higher than the selling price of USD 241.96 on 2025-12-02. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -2,772 @ USD 80.22 | USD -222,370 | The ETF sold 2772 shares of GEHC on 2025-12-02. The shares were previously bought for an average price of USD 79.8893. The GE HealthCare Technologies Inc. shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 917 The average price that the ETF previously sold GEHC share for is USD 79.2097 so the ETF has sold 2772 shares on 2025-12-02 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -891 @ USD 250.85 | USD -223,507 | The ETF sold 891 shares of RMD on 2025-12-02. The shares were previously bought for an average price of USD 246.636. The ResMed Inc shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 3,755 The average price that the ETF previously sold RMD share for is USD 246.948 so the ETF has sold 891 shares on 2025-12-02 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -1,034 @ USD 225.63 | USD -233,301 | The ETF sold 1034 shares of IQV on 2025-12-02. The shares were previously bought for an average price of USD 193.922. The IQVIA Holdings Inc shares were sold for 16.4% higher than average price of previous purchases. This sale made a profit of USD 32,786 The average price that the ETF previously sold IQV share for is USD 189.001 so the ETF has sold 1034 shares on 2025-12-02 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -1,727 @ USD 148.81 | USD -256,995 | The ETF sold 1727 shares of A on 2025-12-02. The shares were previously bought for an average price of USD 133.072. The Agilent Technologies Inc shares were sold for 11.8% higher than average price of previous purchases. This sale made a profit of USD 27,180 The average price that the ETF previously sold A share for is USD 130.305 so the ETF has sold 1727 shares on 2025-12-02 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -1,441 @ USD 205.13 | USD -295,592 | The ETF sold 1441 shares of CAH on 2025-12-02. The shares were previously bought for an average price of USD 148.95. The Cardinal Health Inc shares were sold for 37.7% higher than average price of previous purchases. This sale made a profit of USD 80,955 The average price that the ETF previously sold CAH share for is USD 139.3 so the ETF has sold 1441 shares on 2025-12-02 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -3,575 @ USD 84.71 | USD -302,838 | The ETF sold 3575 shares of EW on 2025-12-02. The shares were previously bought for an average price of USD 74.5534. The Edwards Lifesciences Corp shares were sold for 13.6% higher than average price of previous purchases. This sale made a profit of USD 36,310 The average price that the ETF previously sold EW share for is USD 72.3741 so the ETF has sold 3575 shares on 2025-12-02 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -1,738 @ USD 190.47 | USD -331,037 | The ETF sold 1738 shares of BDX on 2025-12-02. The shares were previously bought for an average price of USD 207.959. The Becton Dickinson and Company shares were sold for -8.4% lower than average price of previous purchases. This resulted in an overall loss of USD 30,396 The average price that the ETF previously sold BDX share for is USD 207.22 which is higher than the selling price of USD 190.47 on 2025-12-02. |
| ZTS - Zoetis Inc | SELL | -2,695 @ USD 124.44 | USD -335,366 | The ETF sold 2695 shares of ZTS on 2025-12-02. The shares were previously bought for an average price of USD 154.809. The Zoetis Inc shares were sold for -19.6% lower than average price of previous purchases. This resulted in an overall loss of USD 81,844 The average price that the ETF previously sold ZTS share for is USD 166.413 which is higher than the selling price of USD 124.44 on 2025-12-02. |
| IDXX - IDEXX Laboratories Inc | SELL | -484 @ USD 732.73 | USD -354,641 | The ETF sold 484 shares of IDXX on 2025-12-02. The shares were previously bought for an average price of USD 534.488. The IDEXX Laboratories Inc shares were sold for 37.1% higher than average price of previous purchases. This sale made a profit of USD 95,949 The average price that the ETF previously sold IDXX share for is USD 481.927 so the ETF has sold 484 shares on 2025-12-02 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -1,166 @ USD 350.67 | USD -408,881 | The ETF sold 1166 shares of COR on 2025-12-02. The shares were previously bought for an average price of USD 298.046. The Cencora Inc. shares were sold for 17.7% higher than average price of previous purchases. This sale made a profit of USD 61,360 The average price that the ETF previously sold COR share for is USD 270.536 so the ETF has sold 1166 shares on 2025-12-02 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -1,617 @ USD 274.1 | USD -443,220 | The ETF sold 1617 shares of CI on 2025-12-02. The shares were previously bought for an average price of USD 301.908. The Cigna Corp shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 44,966 The average price that the ETF previously sold CI share for is USD 315.294 which is higher than the selling price of USD 274.1 on 2025-12-02. |
| ELV - Elevance Health Inc | SELL | -1,364 @ USD 330.92 | USD -451,375 | The ETF sold 1364 shares of ELV on 2025-12-02. The shares were previously bought for an average price of USD 375.554. The Elevance Health Inc shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of USD 60,881 The average price that the ETF previously sold ELV share for is USD 390.701 which is higher than the selling price of USD 330.92 on 2025-12-02. |
| ELV - Elevance Health Inc | SELL | -1,364 @ USD 330.92 | USD -451,375 | The ETF sold 1364 shares of ELV on 2025-12-02. The shares were previously bought for an average price of USD 375.554. The Elevance Health Inc shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of USD 60,881 The average price that the ETF previously sold ELV share for is USD 390.701 which is higher than the selling price of USD 330.92 on 2025-12-02. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -616 @ USD 742 | USD -457,072 | The ETF sold 616 shares of REGN on 2025-12-02. The shares were previously bought for an average price of USD 664.262. The Regeneron Pharmaceuticals Inc shares were sold for 11.7% higher than average price of previous purchases. This sale made a profit of USD 47,887 The average price that the ETF previously sold REGN share for is USD 683.718 so the ETF has sold 616 shares on 2025-12-02 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -990 @ USD 500.31 | USD -495,307 | The ETF sold 990 shares of HCA on 2025-12-02. The shares were previously bought for an average price of USD 382.797. The HCA Holdings Inc shares were sold for 30.7% higher than average price of previous purchases. This sale made a profit of USD 116,338 The average price that the ETF previously sold HCA share for is USD 368.019 so the ETF has sold 990 shares on 2025-12-02 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -12,320 @ USD 48.25 | USD -594,440 | The ETF sold 12320 shares of BMY on 2025-12-02. The shares were previously bought for an average price of USD 52.039. The Bloomsbury Publishing Plc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 46,680 The average price that the ETF previously sold BMY share for is USD 53.1798 which is higher than the selling price of USD 48.25 on 2025-12-02. |
| CVS - CVS Health Corp | SELL | -7,678 @ USD 77.62 | USD -595,966 | The ETF sold 7678 shares of CVS on 2025-12-02. The shares were previously bought for an average price of USD 68.9571. The CVS Health Corp shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 66,514 The average price that the ETF previously sold CVS share for is USD 61.9189 so the ETF has sold 7678 shares on 2025-12-02 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -748 @ USD 829.7 | USD -620,616 | The ETF sold 748 shares of MCK on 2025-12-02. The shares were previously bought for an average price of USD 701.29. The McKesson Corporation shares were sold for 18.3% higher than average price of previous purchases. This sale made a profit of USD 96,051 The average price that the ETF previously sold MCK share for is USD 662.55 so the ETF has sold 748 shares on 2025-12-02 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -1,551 @ USD 433.15 | USD -671,816 | The ETF sold 1551 shares of VRTX on 2025-12-02. The shares were previously bought for an average price of USD 446.865. The Vertex Pharmaceuticals Inc shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 21,272 The average price that the ETF previously sold VRTX share for is USD 467.571 which is higher than the selling price of USD 433.15 on 2025-12-02. |
| SYK - Stryker Corporation | SELL | -2,079 @ USD 366.68 | USD -762,328 | The ETF sold 2079 shares of SYK on 2025-12-02. The shares were previously bought for an average price of USD 375.395. The Stryker Corporation shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of USD 18,118 The average price that the ETF previously sold SYK share for is USD 379.95 which is higher than the selling price of USD 366.68 on 2025-12-02. |
| MDT - Medtronic PLC | SELL | -7,755 @ USD 102.03 | USD -791,243 | The ETF sold 7755 shares of MDT on 2025-12-02. The shares were previously bought for an average price of USD 91.2503. The Medtronic PLC shares were sold for 11.8% higher than average price of previous purchases. This sale made a profit of USD 83,597 The average price that the ETF previously sold MDT share for is USD 87.6413 so the ETF has sold 7755 shares on 2025-12-02 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -34,441 @ USD 25.15 | USD -866,191 | The ETF sold 34441 shares of PFE on 2025-12-02. The shares were previously bought for an average price of USD 25.3617. The Pfizer Inc shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 7,291 The average price that the ETF previously sold PFE share for is USD 25.3709 which is higher than the selling price of USD 25.15 on 2025-12-02. |
| DHR - Danaher Corporation | SELL | -3,850 @ USD 226.59 | USD -872,372 | The ETF sold 3850 shares of DHR on 2025-12-02. The shares were previously bought for an average price of USD 214.347. The Danaher Corporation shares were sold for 5.7% higher than average price of previous purchases. This sale made a profit of USD 47,136 The average price that the ETF previously sold DHR share for is USD 222.221 so the ETF has sold 3850 shares on 2025-12-02 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -3,850 @ USD 226.59 | USD -872,372 | The ETF sold 3850 shares of DHR on 2025-12-02. The shares were previously bought for an average price of USD 214.347. The Danaher Corporation shares were sold for 5.7% higher than average price of previous purchases. This sale made a profit of USD 47,136 The average price that the ETF previously sold DHR share for is USD 222.221 so the ETF has sold 3850 shares on 2025-12-02 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -8,965 @ USD 99.02 | USD -887,714 | The ETF sold 8965 shares of BSX on 2025-12-02. The shares were previously bought for an average price of USD 99.4294. The Boston Scientific Corporation shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,670 The average price that the ETF previously sold BSX share for is USD 94.8469 so the ETF has sold 8965 shares on 2025-12-02 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -8,965 @ USD 99.02 | USD -887,714 | The ETF sold 8965 shares of BSX on 2025-12-02. The shares were previously bought for an average price of USD 99.4294. The MULSTRXSSXIMETFP shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,670 The average price that the ETF previously sold BSX share for is USD 94.8469 so the ETF has sold 8965 shares on 2025-12-02 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -7,513 @ USD 123.91 | USD -930,936 | The ETF sold 7513 shares of GILD on 2025-12-02. The shares were previously bought for an average price of USD 109.187. The Guild Esports Plc shares were sold for 13.5% higher than average price of previous purchases. This sale made a profit of USD 110,614 The average price that the ETF previously sold GILD share for is USD 101.155 so the ETF has sold 7513 shares on 2025-12-02 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -3,256 @ USD 338.36 | USD -1,101,700 | The ETF sold 3256 shares of AMGN on 2025-12-02. The shares were previously bought for an average price of USD 302.719. The Amgen Inc shares were sold for 11.8% higher than average price of previous purchases. This sale made a profit of USD 116,047 The average price that the ETF previously sold AMGN share for is USD 295.246 so the ETF has sold 3256 shares on 2025-12-02 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -2,167 @ USD 567.72 | USD -1,230,249 | The ETF sold 2167 shares of ISRG on 2025-12-02. The shares were previously bought for an average price of USD 523.887. The Intuitive Surgical Inc shares were sold for 8.4% higher than average price of previous purchases. This sale made a profit of USD 94,986 The average price that the ETF previously sold ISRG share for is USD 529.923 so the ETF has sold 2167 shares on 2025-12-02 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -2,277 @ USD 580.37 | USD -1,321,502 | The ETF sold 2277 shares of TMO on 2025-12-02. The shares were previously bought for an average price of USD 522.412. The Time Out Group plc shares were sold for 11.1% higher than average price of previous purchases. This sale made a profit of USD 131,970 The average price that the ETF previously sold TMO share for is USD 497.813 so the ETF has sold 2277 shares on 2025-12-02 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -10,527 @ USD 126.32 | USD -1,329,771 | The ETF sold 10527 shares of ABT on 2025-12-02. The shares were previously bought for an average price of USD 128.328. The Abbott Laboratories shares were sold for -1.6% lower than average price of previous purchases. This resulted in an overall loss of USD 21,138 The average price that the ETF previously sold ABT share for is USD 123.294 so the ETF has sold 10527 shares on 2025-12-02 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -15,103 @ USD 101.03 | USD -1,525,856 | The ETF sold 15103 shares of MRK on 2025-12-02. The shares were previously bought for an average price of USD 89.997. The Marks Electrical Group PLC shares were sold for 12.3% higher than average price of previous purchases. This sale made a profit of USD 166,631 The average price that the ETF previously sold MRK share for is USD 93.013 so the ETF has sold 15103 shares on 2025-12-02 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -15,103 @ USD 101.03 | USD -1,525,856 | The ETF sold 15103 shares of MRK on 2025-12-02. The shares were previously bought for an average price of USD 89.997. The Merck & Company Inc shares were sold for 12.3% higher than average price of previous purchases. This sale made a profit of USD 166,631 The average price that the ETF previously sold MRK share for is USD 93.013 so the ETF has sold 15103 shares on 2025-12-02 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -5,467 @ USD 324.54 | USD -1,774,260 | The ETF sold 5467 shares of UNH on 2025-12-02. The shares were previously bought for an average price of USD 434.856. The UnitedHealth Group Incorporated shares were sold for -25.4% lower than average price of previous purchases. This resulted in an overall loss of USD 603,098 The average price that the ETF previously sold UNH share for is USD 477.675 which is higher than the selling price of USD 324.54 on 2025-12-02. |
| ABBV - AbbVie Inc | SELL | -10,670 @ USD 224.37 | USD -2,394,028 | The ETF sold 10670 shares of ABBV on 2025-12-02. The shares were previously bought for an average price of USD 204.216. The AbbVie Inc shares were sold for 9.9% higher than average price of previous purchases. This sale made a profit of USD 215,043 The average price that the ETF previously sold ABBV share for is USD 191.184 so the ETF has sold 10670 shares on 2025-12-02 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -14,553 @ USD 205.42 | USD -2,989,477 | The ETF sold 14553 shares of JNJ on 2025-12-02. The shares were previously bought for an average price of USD 169.608. The Johnson & Johnson shares were sold for 21.1% higher than average price of previous purchases. This sale made a profit of USD 521,172 The average price that the ETF previously sold JNJ share for is USD 158.606 so the ETF has sold 14553 shares on 2025-12-02 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -4,796 @ USD 1046.12 | USD -5,017,192 | The ETF sold 4796 shares of LLY on 2025-12-02. The shares were previously bought for an average price of USD 844.311. The Eli Lilly and Company shares were sold for 23.9% higher than average price of previous purchases. This sale made a profit of USD 967,876 The average price that the ETF previously sold LLY share for is USD 804.089 so the ETF has sold 4796 shares on 2025-12-02 at a higher price than the previous selling average. |